Article
Association of ABCC2 polymorphism and gender with high-density lipoprotein cholesterol response to simvastatin.
Pharmacogenomics - 1 Sept 2018
Liu Na, Yang Guihua, Hu Mei, Cai Yuyu, Hu Zhiying, Jia Chundi, Zhang Man
Abstract excerpt
AIM: The clinical benefits of lipid-lowering therapy with statins are widely recognized. However, the lipid-lowering efficacy of statins shows significant differences between individuals. ABCC2 has been demonstrated to contribute to the transmembrane transport of the substrate compounds. The ABCC2 SNPs may be important factors that affect individual differences in clinical drug response. The aim of this study was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
